The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials

Ovarian cancer (OC) remains the most lethal gynecological malignancy, primarily due to its late-stage diagnosis, frequent recurrence, and resistance to conventional chemotherapy. A critical factor contributing to OC’s aggressiveness is the tumor microenvironment (TME), particularly the presence and...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenchen Xu, Jiyu Chen, Mi Tan, Qingqing Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1543096/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850156333343440896
author Chenchen Xu
Jiyu Chen
Mi Tan
Qingqing Tan
author_facet Chenchen Xu
Jiyu Chen
Mi Tan
Qingqing Tan
author_sort Chenchen Xu
collection DOAJ
description Ovarian cancer (OC) remains the most lethal gynecological malignancy, primarily due to its late-stage diagnosis, frequent recurrence, and resistance to conventional chemotherapy. A critical factor contributing to OC’s aggressiveness is the tumor microenvironment (TME), particularly the presence and polarization of tumor-associated macrophages (TAMs). TAMs, often skewed toward an immunosuppressive M2-like phenotype, facilitate tumor growth, angiogenesis, metastasis, and resistance to therapy. This comprehensive review delves into the multifaceted regulation of macrophage polarization in OC, highlighting key molecular pathways such as PTEN loss, Wnt/β-catenin signaling, NF-κB, Myc, STAT3, and JNK, among others. Additionally, it explores the role of chemokines, non-coding RNAs, and various proteins in modulating TAM phenotypes. Emerging evidence underscores the significance of extracellular vesicles (EVs) and ovarian cancer stem cells (CSCs) in promoting M2 polarization, thereby enhancing tumor progression and therapy resistance. The review also identifies critical biomarkers associated with macrophage polarization, including CD163, LILRB1, MUC2, and others, which hold prognostic and therapeutic potential. Therapeutic strategies targeting TAMs are extensively discussed, encompassing oncolytic viruses, engineered EVs, immunotherapies, nanoparticles, targeted therapies, and natural products. These approaches aim to reprogram TAMs from a pro-tumorigenic M2 state to an anti-tumorigenic M1 phenotype, thereby enhancing immune responses and overcoming resistance to treatments such as chemotherapy and immune checkpoint inhibitors. Furthermore, the review addresses the interplay between macrophage polarization and therapy resistance, emphasizing the need for novel interventions to modulate the TME effectively. By synthesizing current knowledge on macrophage polarization in ovarian cancer, this study underscores the potential of targeting TAMs to improve clinical outcomes and personalize treatment strategies for OC patients. Continued research in this domain is essential to develop robust therapeutic frameworks that can mitigate the immunosuppressive TME and enhance the efficacy of existing and novel cancer therapies.
format Article
id doaj-art-b2ef78842f99457ab066cb5ccc5c9549
institution OA Journals
issn 1664-3224
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-b2ef78842f99457ab066cb5ccc5c95492025-08-20T02:24:34ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-04-011610.3389/fimmu.2025.15430961543096The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentialsChenchen XuJiyu ChenMi TanQingqing TanOvarian cancer (OC) remains the most lethal gynecological malignancy, primarily due to its late-stage diagnosis, frequent recurrence, and resistance to conventional chemotherapy. A critical factor contributing to OC’s aggressiveness is the tumor microenvironment (TME), particularly the presence and polarization of tumor-associated macrophages (TAMs). TAMs, often skewed toward an immunosuppressive M2-like phenotype, facilitate tumor growth, angiogenesis, metastasis, and resistance to therapy. This comprehensive review delves into the multifaceted regulation of macrophage polarization in OC, highlighting key molecular pathways such as PTEN loss, Wnt/β-catenin signaling, NF-κB, Myc, STAT3, and JNK, among others. Additionally, it explores the role of chemokines, non-coding RNAs, and various proteins in modulating TAM phenotypes. Emerging evidence underscores the significance of extracellular vesicles (EVs) and ovarian cancer stem cells (CSCs) in promoting M2 polarization, thereby enhancing tumor progression and therapy resistance. The review also identifies critical biomarkers associated with macrophage polarization, including CD163, LILRB1, MUC2, and others, which hold prognostic and therapeutic potential. Therapeutic strategies targeting TAMs are extensively discussed, encompassing oncolytic viruses, engineered EVs, immunotherapies, nanoparticles, targeted therapies, and natural products. These approaches aim to reprogram TAMs from a pro-tumorigenic M2 state to an anti-tumorigenic M1 phenotype, thereby enhancing immune responses and overcoming resistance to treatments such as chemotherapy and immune checkpoint inhibitors. Furthermore, the review addresses the interplay between macrophage polarization and therapy resistance, emphasizing the need for novel interventions to modulate the TME effectively. By synthesizing current knowledge on macrophage polarization in ovarian cancer, this study underscores the potential of targeting TAMs to improve clinical outcomes and personalize treatment strategies for OC patients. Continued research in this domain is essential to develop robust therapeutic frameworks that can mitigate the immunosuppressive TME and enhance the efficacy of existing and novel cancer therapies.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1543096/fullovarian cancertumor-associated macrophagesmacrophage polarizationtumor microenvironmenttherapy resistancebiomarkers
spellingShingle Chenchen Xu
Jiyu Chen
Mi Tan
Qingqing Tan
The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
Frontiers in Immunology
ovarian cancer
tumor-associated macrophages
macrophage polarization
tumor microenvironment
therapy resistance
biomarkers
title The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
title_full The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
title_fullStr The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
title_full_unstemmed The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
title_short The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
title_sort role of macrophage polarization in ovarian cancer from molecular mechanism to therapeutic potentials
topic ovarian cancer
tumor-associated macrophages
macrophage polarization
tumor microenvironment
therapy resistance
biomarkers
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1543096/full
work_keys_str_mv AT chenchenxu theroleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT jiyuchen theroleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT mitan theroleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT qingqingtan theroleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT chenchenxu roleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT jiyuchen roleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT mitan roleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials
AT qingqingtan roleofmacrophagepolarizationinovariancancerfrommolecularmechanismtotherapeuticpotentials